Author: Brittney Wheeler

In a small study, researchers at Washington University School of Medicine found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients.

Researchers at Washington University School of Medicine have used light to decode brain signals and identify what image a person sees. It could be a step toward helping people who are unable to express themselves because of brain injury or disease communicate.

Researchers at Washington University School of Medicine have engineered cartilage cells to release an anti-inflammatory drug in response to stresses such cells undergo when they are compressed during weight bearing and movement.

Researchers at Washington University School of Medicine have found that immune cells stationed in such sinuses monitor the brain and initiate an immune response if they detect a problem.

A new study from Washington University School of Medicine suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer.

Researchers at Washington University School of Medicine have developed an imaging agent that could help refine assessments of kidney health, potentially salvaging some otherwise discarded donor kidneys.

Researchers at Washington University School of Medicine in St. Louis have found that a protein involved in regulating lipid levels in the liver and blood also promotes development and progression of fatty liver disease and liver cancer in mice.

Researchers at Washington University School of Medicine in St. Louis have found that patients with Barrett’s esophagus may be vulnerable to coronavirus infection from what they swallow.

A new study from Washington University School of Medicine in St. Louis suggests that measuring mitochondrial DNA in the blood of patients with COVID-19 can help predict which patients are at highest risk of severe disease, requiring more intensive care.

New School of Medicine research indicates that allergens in the environment often are to blame for episodes of acute itch in eczema patients. Researchers found the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don’t target.